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STATE-OF-THE-ART PAPERS STATE-OF-THE-ART PAPERSPercutaneous Approaches for Mitral Regurgitation 2057Ted Feldman, Amelia Young
Transcatheter-based approaches for the treatment of clinically signiﬁcant mitral regurgitation
have evolved over the last decade. In this state-of-the-art paper, Feldman and Young review
the available techniques, outcomes of previous clinical trials, and future areas of development.STATE-OF-THE-ART PAPERSInotropes 2069
Gary S. Francis, Jason A. Bartos, Sirtaz Adatya
Inotropes have been fundamental to the resuscitation of patients with acute cardiogenic
shock. This review describes the mechanisms of action and clinical utility of some of the
inotropic agents currently in use. Newer agents under development are also discussed.VIEWPOINT VIEWPOINTSupply/Demand Type 2 Myocardial Infarction 2079
Yader Sandoval, Stephen W. Smith, Sarah E. Thordsen, Fred S. Apple
In 2007, the second universal deﬁnition of MI introduced and deﬁned 5 different MI
subtypes. Type 2 MI was deﬁned as MI due to supply/demand mismatch, without plaque
rupture, but with myocardial necrosis evidenced by a rise and/or fall of cardiac biomarkers. In
this state-of-the-art paper, the authors review the available data on this entity, including
etiology, pathophysiology, prognosis, and management.(continued on page A-31)
MAY 27, 2014 (continued)CLINICAL RESEARCHA-31INTERVENTIONAL CARDIOLOGYThe DEFER-STEMI Proof-of-Concept Trial 2088
David Carrick, Keith G. Oldroyd, Margaret McEntegart, Caroline Haig, Mark C. Petrie,
Hany Eteiba, Stuart Hood, Colum Owens, Stuart Watkins, Jamie Layland, Mitchell Lindsay, Eileen Peat,
Alan Rae, Miles Behan, Arvind Sood, W. Stewart Hillis, Ify Mordi, Ahmed Mahrous, Nadeem Ahmed,
Rebekah Wilson, Laura Lasalle, Philippe Généreux, Ian Ford, Colin Berry
The objective of this study was to assess whether deferred stenting may reduce no-reﬂow and
salvage myocardium in primary percutaneous coronary intervention (PCI) for ST-segment
elevation myocardial infarction (STEMI). Randomization was to deferred stenting with an
intention to stent 4 to 16 h later (n ¼ 52) or conventional treatment with immediate stenting
(n ¼ 49). Fewer patients in the deferred stenting group had no/slow-reﬂow (29% vs. 6%),
no-reﬂow (14% vs. 2%), and intraprocedural thrombotic events (33% vs. 10%). Carrick and
colleagues conclude that, in high-risk STEMI patients, deferred stenting in primary PCI
reduced no-reﬂow and increased myocardial salvage.
Editorial Comment: David Antoniucci, p. 2099INTERVENTIONAL CARDIOLOGYStroke After TAVR: Inﬂuence of TAVR Strategy and Valve Design 2101
Ganesh Athappan, R. Dilip Gajulapalli, Prasanna Sengodan, Anju Bhardwaj, Stephen G. Ellis,
Lars Svensson, Emin Murat Tuzcu, Samir R. Kapadia
Athappan and colleagues performed a review to establish and compare the risk of stroke
between 2 widely used approaches (transfemoral vs. transapical) and valve design (CoreValve
vs. Edwards valve) for transcatheter aortic valve replacement (TAVR). There was no
difference in pooled 30-day stroke post-TAVR between the 2 approaches in multicenter
(2.8%) and single-center studies (3.8%). There was also no difference in pooled 30-day stroke
post-TAVR between the CoreValve and Edwards valves in multicenter (2.4%) and single-
center studies (3.8%). The ﬁndings suggest that the risk of 30-day stroke after TAVR is
similar between approaches and valve types.(continued on page A-32)
MAY 27, 2014 (continued) A-32INTERVENTIONAL CARDIOLOGYDES in Patients With and Without Diabetes 2111
Elvin Kedhi, Philippe Généreux, Tullio Palmerini, Thomas C. McAndrew, Helen Parise,
Roxana Mehran, George D. Dangas, Gregg W. Stone
This study investigated whether baseline lesion complexity affects drug-eluting stent (DES)
outcomes according to diabetic status. Patient-level data from 18 prospective randomized
trials were pooled. Target lesion revascularization and target vessel revascularization were
signiﬁcantly higher in diabetes mellitus (DM) versus non-DM patients with American
College of Cardiology/American Heart Association type B2/C lesions (8.0% vs. 4.5% and
10.6% vs. 5.9%, respectively), but not in type A/B1 lesions. Kedhi and colleagues conclude
that DM is a risk factor for repeat revascularization only in those patients with complex
lesions.
Editorial Comment: Stephen G. Ellis, p. 2119CARDIOMETABOLIC RISKOpposing Effects of ABCG5/8 Function on MI and Gallstones 2121
Stefan Stender, Ruth Frikke-Schmidt, Børge G. Nordestgaard, Anne Tybjærg-Hansen
This study tested the hypothesis that genetic variation in adenosine triphosphate–binding
cassette transporter G5/8 (ABCG5/8), the transporter responsible for intestinal and
hepatobiliary cholesterol efﬂux, might inﬂuence plasma and biliary cholesterol levels, and
hence, risk of myocardial infarction (MI) and gallstone disease, in opposite directions. A total
of 60,239 subjects (5,647 with MI and 3,174 with symptomatic gallstone disease) were
genotyped, and a combined weighted genetic score was calculated. The odds ratios were 0.83
for myocardial infarction and 2.85 for symptomatic gallstone disease for individuals with a
genotype score 8.0 versus <2.0. Results reveal that genetic variation in ABCG5/8, which
associates with decreased levels of plasma low-density lipoprotein cholesterol, protects against
MI but increases the risk of symptomatic gallstone disease.
Editorial Comment: William Hancock-Cerutti, Daniel J. Rader, p. 2129(continued on page A-33)
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Koji Tokioka, Kengo F. Kusano, Hiroshi Morita, Daiji Miura, Nobuhiro Nishii, Satoshi Nagase,
Kazufumi Nakamura, Kunihisa Kohno, Hiroshi Ito, Tohru Ohe
This study aimed to determine the usefulness of the combination of several
electrocardiographic (ECG) markers on risk assessment of ventricular ﬁbrillation (VF) in
patients with Brugada syndrome (BrS). Baseline characteristics of 246 consecutive patients
with Brugada-type ECG, including 13 patients with a history of VF and 40 patients with a
history of syncopal episodes, were retrospectively analyzed. By multivariable analysis, history
of VF, history of syncopal episodes, inferolateral early repolarization pattern, and fragmented
QRS were independent predictors of documented VF and sudden cardiac death (odds ratios:
19.61, 28.57, 2.87, and 5.21, respectively). The combination of depolarization and
repolarization abnormalities in BrS is associated with later VF events and may be useful in
risk stratifying these patients.
Editorial Comment: Koonlawee Nademanee, Gumpanart Veerakul, p. 2139HEART RHYTHM DISORDERSRisk Factors for Anticoagulation in Atrial Fibrillation: A Dilemma 2141
Elaine M. Hylek, Claes Held, John H. Alexander, Renato D. Lopes, Raffaele De Caterina,
Daniel M. Wojdyla, Kurt Huber, Petr Jansky, Philippe Gabriel Steg, Michael Hanna, Laine Thomas,
Lars Wallentin, Christopher B. Granger
This study attempts to identify the characteristics, risk factors, and the incidence of 30-day
mortality associated with major bleeding among individuals with atrial ﬁbrillation. Patients
who received at least 1 dose of study drug and were enrolled in the ARISTOTLE (Apixaban
for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial were
evaluated. The rate of major hemorrhage among patients in the apixaban group was 2.13%/
year compared with 3.09% per year in the warfarin group (hazard ratio: 0.69). Major
hemorrhage followed by mortality within 30 days occurred one-half as often in the apixaban-
treated patients. Apixaban compared with warfarin was associated with fewer intracranial
hemorrhages, less adverse consequences following extracranial hemorrhage, and a 50%
reduction in fatal consequences at 30 days in cases of major hemorrhage.
Editorial Comment: Michael H. Kim, p. 2148(continued on page A-34)
MAY 27, 2014 (continued) A-34HEART RHYTHM DISORDERSPVC Coupling Interval Variability 2151Jason S. Bradﬁeld, Mohamed Homsi, Kalyanam Shivkumar, John M. Miller
The objective of this study was to determine whether premature ventricular contractions
(PVCs) arising from the aortic sinuses of Valsalva (SOV) and great cardiac vein (GCV) have
coupling interval (CI) characteristics that differentiate them from other ectopic foci. A total
of 73 consecutive patients referred for PVC ablation were assessed, and the DCI (max-min
CI) was measured. A DCI of >60 ms demonstrated a sensitivity of 89%, speciﬁcity of 100%,
positive predictive value of 100%, and negative predictive value of 94% for SOV/GCV origin
of the PVC. The study concludes that DCI is more pronounced in PVCs originating from
the SOV or GCV. A DCI of 60 ms helps discriminate the origin of PVCs before diagnostic
electrophysiological study and may be associated with increased frequency of cardiac events.PEDIATRIC CARDIOLOGYSurvival in Pediatric Pulmonary Hypertension 2159
Willemijn M. H. Zijlstra, Johannes M. Douwes, Erika B. Rosenzweig, Sandor Schokker,
Usha Krishnan, Marcus T. R. Roofthooft, Kathleen Miller-Reed, Hans L. Hillege, D. Dunbar Ivy,
Rolf M. F. Berger
The objective of this study was to describe survival and treatment strategies in pediatric
pulmonary arterial hypertension (PAH) and to identify predictors of outcome. A total of 275
patients from 3 referral centers were studied. Overall 1-, 3-, 5-, and 7-year transplant-free
survival rates were 96%, 89%, 81%, and 79%, respectively, and did not differ among centers
after adjusting for clinical and hemodynamic patient characteristics. Additionally, treatment
with PAH-targeted dual and triple therapy was associated with better survival than treatment
with monotherapy.
